ABHD2 exhibits diverse enzymatic and regulatory activities:
Acts as a triacylglycerol (TAG) lipase, hydrolyzing TAGs into free fatty acids and glycerol .
Demonstrates ester hydrolase activity against substrates like p-nitrophenyl acetate, butyrate, and palmitate .
Regulates mitochondrial phospholipids (e.g., cardiolipin, phosphatidylglycerol) in murine liver, impacting membrane stability .
Functions as a non-genomic progesterone receptor: Progesterone binding activates its lipase activity, degrading endocannabinoids like 2-arachidonoylglycerol (2-AG) .
Critical for sperm capacitation by modulating calcium influx via CatSper channels .
COPD: Downregulation correlates with airway remodeling via TGF-β-mediated epithelial-mesenchymal transition (EMT) .
Cancer: Modulates anoikis resistance in ovarian cancer and influences metastatic potential .
Enzyme Activity: Recombinant ABHD2 expressed in Saccharomyces cerevisiae showed TAG lipase activity (specific activity: 12.5 U/mg) .
Mutational Analysis: Ser-207→Ala mutation abolished ligand binding, confirming its catalytic role .
Knockout Mice:
COPD Models: Abhd2-deficient mice exhibited exacerbated emphysema and airway thickening .
| Application | Use Case | Reference |
|---|---|---|
| Lipidomics | Quantifying phospholipid remodeling | |
| Reproductive Biology | Studying progesterone-mediated signaling | |
| Drug Discovery | Targeting TAG lipases for metabolic disorders |
Recombinant Macaca fascicularis Abhydrolase domain-containing protein 2 (ABHD2) is a progesterone-dependent acylglycerol lipase. It catalyzes the hydrolysis of the endocannabinoid arachidonoylglycerol (AG) from cell membranes. ABHD2 functions as a progesterone receptor; progesterone binding activates its acylglycerol lipase activity, mediating the degradation of 1-arachidonoylglycerol (1AG) and 2-arachidonoylglycerol (2AG) into glycerol and arachidonic acid (AA). It also exhibits ester hydrolase activity against acetyl, butanoate, and hexadecanoate esters. ABHD2 plays a crucial role in sperm capacitation in response to progesterone by degrading 2AG, an inhibitor of the sperm calcium channel CatSper, thereby enabling calcium influx via CatSper and sperm activation. It may also be involved in smooth muscle cell migration.
KEGG: mcf:101867085
UniGene: Mfa.7402
ABHD2 (abhydrolase domain containing 2) is a protein containing an alpha/beta hydrolase fold, which is a catalytic domain found in a wide range of enzymes . This structural motif is conserved across species and serves as the foundation for the protein's enzymatic activity. The structure consists of parallel beta-sheets surrounded by alpha-helices, creating a characteristic fold that positions the catalytic residues for optimal substrate interaction and catalysis.
The full-length amino acid sequence of Macaca fascicularis ABHD2 (UniProt ID: Q4R2Y9) consists of 425 amino acids. The sequence begins with MNAMLETPELPAVFDGVKLAAVAAVLYVIVRCLNLKSPTAPPDLYFQDSGLSRFLLKSCP and continues through to EADLE at the C-terminus . The protein contains regions critical for enzymatic function, membrane association, and regulatory interactions with other biomolecules.
ABHD2 plays several key roles in lipid metabolism, particularly in the synthesis, turnover, and remodeling of phospholipids . It functions as a monoacylglycerol lipase with demonstrated effects on male fertility and ovulation in female mice. In sperm cells, ABHD2 is activated by progesterone and cleaves monoacylglycerols (including 1-arachadonoylglycerol and 2-arachadonoylglycerol) to remove inhibition of the CatSper calcium channel, thereby enabling sperm activation . Additionally, ABHD2 appears to have tissue-specific roles, including potential involvement in mitochondrial lipid regulation.
Recombinant ABHD2 protein should be stored at -20°C for regular use, while extended storage requires -20°C to -80°C conditions . It is crucial to avoid repeated freeze-thaw cycles as these can compromise protein integrity and enzymatic activity. For ongoing experiments, working aliquots can be maintained at 4°C for up to one week . When preparing aliquots, use sterile techniques and store in appropriate buffer conditions (typically a Tris-based buffer with 50% glycerol) to maintain stability and prevent protein aggregation or degradation.
For protein-protein interaction studies, recombinant ABHD2 can be conjugated to magnetic beads, which offer uniform particle size and narrow size distribution with large surface area for efficient target molecule capture . This approach enables convenient and rapid magnetic separation with high specificity. The pre-coupled magnetic beads can be used in immunoprecipitation and co-precipitation experiments to identify and characterize ABHD2 binding partners. These methods can be integrated with mass spectrometry for comprehensive interactome analysis or used in targeted approaches to validate specific interactions.
When designing enzymatic assays with ABHD2, researchers should include several critical controls:
Negative control: Heat-inactivated ABHD2 to demonstrate specificity of enzymatic activity
Substrate controls: Varying concentrations of substrates (particularly monoacylglycerols) to establish enzyme kinetics
Competitive inhibitors: Known inhibitors of alpha/beta hydrolases to confirm mechanism
Positive control: Well-characterized hydrolase with similar substrate specificity
Buffer controls: To rule out buffer components influencing observed activity
Additionally, time-course experiments should be performed to establish linear ranges of enzymatic activity, and pH optimization should be conducted to determine optimal reaction conditions.
Studies in knockout mice have revealed tissue-specific effects of ABHD2 on phospholipid profiles. In liver tissue, ABHD2 knockout resulted in increased levels of phosphatidylcholine (PC) and phosphatidylethanolamine (PE), suggesting a role in phospholipid degradation . Interestingly, male knockout mice exhibited decreased levels of mitochondrial lipids, specifically cardiolipin and phosphatidylglycerol . This contrasts with findings in lung tissue, where ABHD2 deficiency led to decreased PC levels in bronchoalveolar lavage fluid .
To effectively study these tissue-specific differences, researchers should employ:
Targeted lipidomics approaches focusing on phospholipid species
Complementary transcriptomic analysis to identify compensatory mechanisms
In vitro enzymatic assays with tissue-derived substrates
Subcellular fractionation to determine compartment-specific effects
Investigating ABHD2 substrate specificity requires a multi-faceted approach:
In vitro enzymatic assays: Using purified recombinant ABHD2 with defined substrates to determine kinetic parameters (Km, Vmax, kcat) for various potential substrates
Lipid overlay assays: To screen broader classes of potential lipid substrates
Activity-based protein profiling: Using activity-based probes specific for serine hydrolases
Comparative lipidomics: Between wild-type and ABHD2-deficient samples to identify accumulating substrates
Structural modeling and docking studies: To predict substrate binding and catalytic mechanisms
Genetic studies have revealed an inverse relationship between ABHD2 expression and phospholipid levels, indicative of a "substrate signature," suggesting direct involvement in phospholipid degradation pathways .
Comparing ABHD2 function across species requires:
Sequence alignment and structural analysis: To identify conserved domains and species-specific variations
Recombinant expression of both variants: Production of both human and Macaca fascicularis ABHD2 under identical conditions
Comparative enzymatic assays: Using identical substrates and conditions to detect functional differences
Cell-based reconstitution studies: Expressing each variant in ABHD2-knockout cells
Phospholipidomic profiling: To identify species-specific effects on the lipidome
When conducting these analyses, researchers should consider that while the catalytic domain is likely conserved, regulatory mechanisms and protein-protein interactions may exhibit species-specific differences that influence function in complex biological systems.
Mammalian expression systems, particularly HEK293 cells, are recommended for producing functional recombinant Macaca fascicularis ABHD2 . These systems provide appropriate post-translational modifications and protein folding machinery essential for proper enzyme activity. Consider the following factors when selecting an expression system:
Post-translational modifications: Mammalian systems ensure proper glycosylation patterns
Protein solubility: Addition of solubility tags (His, GST, etc.) may enhance expression
Purification strategy: Incorporation of affinity tags facilitates downstream purification
Scale requirements: Transient vs. stable expression depending on protein quantity needed
Activity preservation: Gentle purification methods to maintain enzymatic activity
Expression in E. coli systems is possible but may result in inclusion body formation requiring refolding protocols that can compromise activity.
Reliable quantification of ABHD2 activity can be achieved through several complementary approaches:
Fluorogenic substrate assays: Using substrates that release fluorescent products upon hydrolysis
Radiometric assays: Employing radiolabeled substrates to measure product formation
HPLC-based assays: Separating and quantifying substrate and product
Mass spectrometry: For direct detection of lipid substrates and products
Coupled enzyme assays: Linking ABHD2 activity to a secondary reaction with easily measurable output
When developing activity assays, researchers should establish linear range, optimize enzyme concentration and reaction time, and validate with known inhibitors. The enzymatic classification (EC= 3.1.1.-) suggests ABHD2 functions as a carboxylic ester hydrolase, which should guide substrate selection .
When confronted with conflicting data regarding ABHD2 function, researchers should:
Consider tissue-specific context: ABHD2 may have different roles in liver versus lung tissue, as evidenced by opposite effects on phospholipid levels
Examine regulatory networks: Evaluate tissue-specific regulatory mechanisms that may alter ABHD2 function
Assess methodology differences: Consider how different experimental approaches (in vivo vs. in vitro) might lead to divergent results
Evaluate genetic background effects: Strain differences in mouse models can significantly impact phenotypes
Investigate compensatory mechanisms: Related enzymes might compensate for ABHD2 deficiency in certain tissues
Current literature shows that ABHD2 knockout increases phosphatidylcholine in liver but decreases it in lung tissue , suggesting complex tissue-specific regulation that warrants careful experimental design when extrapolating findings across tissues.
Bioinformatic analysis of ABHD2 can provide valuable insights through:
Multiple sequence alignment: Compare ABHD2 sequences across species to identify conserved regions
Phylogenetic analysis: Determine evolutionary relationships and functional divergence
Protein domain prediction: Identify functional domains beyond the alpha/beta hydrolase fold
Structural modeling: Predict three-dimensional structure based on homology to crystallized hydrolases
Molecular dynamics simulations: Investigate potential substrate interactions and catalytic mechanisms
The alpha/beta hydrolase fold is highly conserved across the ABHD family, but substrate specificity determinants may vary. Combining these approaches with experimental validation can elucidate structure-function relationships and guide targeted mutagenesis studies.
Researchers commonly encounter several challenges when working with recombinant ABHD2:
Low enzymatic activity: Ensure proper folding by optimizing expression conditions and purification protocols
Protein aggregation: Use appropriate detergents and buffer systems to maintain solubility
Inconsistent activity measurements: Standardize assay conditions and enzyme concentration
Degradation during storage: Aliquot protein to avoid freeze-thaw cycles and add protease inhibitors
Non-specific binding in interaction studies: Include appropriate blocking agents and stringent washing steps
When working with ABHD2-conjugated magnetic beads, avoid freeze-thawing the beads as this can cause aggregation and loss of binding capacity . Additionally, thoroughly equilibrate beads in working buffer before use to ensure optimal binding conditions.
Distinguishing direct from indirect effects requires:
In vitro reconstitution: Use purified components to demonstrate direct enzymatic activity
Catalytic site mutations: Create point mutations in catalytic residues to generate enzymatically inactive controls
Temporal analysis: Monitor rapid changes that likely represent direct effects versus delayed responses
Substrate trapping mutants: Develop variants that bind but do not process substrates
Proximity labeling approaches: Identify proteins in direct physical proximity to ABHD2
The genetic evidence showing inverse correlation between ABHD2 expression and phospholipid levels suggests a direct enzymatic relationship , but cell signaling cascades initiated by ABHD2 activity may lead to numerous secondary effects that require careful experimental design to deconvolute.